Systemic immune-inflammation index and all-cause and cause-specific mortality in sarcopenia: a study from National Health and Nutrition Examination Survey 1999-2018
Open Access
- 4 April 2024
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 15, 1376544
Abstract
Background: Sarcopenia, common in the elderly, often linked to chronic diseases, correlates with inflammation.The association between SII and mortality in sarcopenia patients is underexplored, this study investigates this relationship in a U.S. adult cohort.Methods: We analyzed 1999–2018 NHANES data, focusing on 2,974 adults with sarcopenia. Mortality outcomes were determined by linking to National Death Index (NDI) records up to December 31, 2019. Using a weighted sampling design, participants were grouped into three groups by the Systemic Immune-Inflammation Index (SII). We used Cox regression models, adjusting for demographic and clinical variables, to explore SII’s association with all-cause and cause-specific mortality in sarcopenia, performing sensitivity analyses for robustness.Results: Over a median follow-up of 9.2 years, 829 deaths occurred. Kaplan-Meier analysis showed significant survival differences across SII groups. The highest SII group showed higher hazard ratios (HRs) for all-cause and cause-specific mortality in both crude and adjusted models. The highest SII group had a higher HR for all-cause(1.57, 1.25–1.98), cardiovascular(1.61, 1.00–2.58), cancer(2.13, 1.32–3.44), and respiratory disease mortality(3.21, 1.66–6.19) in fully adjusted models. Subgroup analyses revealed SII’s association with all-cause mortality across various demographics, including age, gender, and presence of diabetes or cardiovascular disease. Sensitivity analyses, excluding participants with cardiovascular diseases, those who died within two years of follow-up, or those under 45 years of age, largely reflected these results, with the highest SII group consistently demonstrating higher HRs for all types of mortality in both unadjusted and adjusted models.Conclusion: Our study is the first to demonstrate a significant relationship between SII and increased mortality risks in a sarcopenia population.Keywords
This publication has 45 references indexed in Scilit:
- Association Between Psoriasis and Nonalcoholic Fatty Liver Disease Among Outpatient US AdultsJAMA Dermatology, 2022
- Systemic inflammation with sarcopenia predicts survival in patients with gastric cancerJournal of Cancer Research and Clinical Oncology, 2022
- Association between sarcopenia and cardiovascular disease among middle-aged and older adults: Findings from the China health and retirement longitudinal studyeClinicalMedicine, 2022
- Amelioration of diabetes‐induced inflammation mediated pyroptosis, sarcopenia, and adverse muscle remodelling by bone morphogenetic protein‐7Journal of Cachexia, Sarcopenia and Muscle, 2021
- Markers of inflammation and their association with muscle strength and mass: A systematic review and meta-analysisAgeing Research Reviews, 2020
- Sarcopenia and adverse health‐related outcomes: An umbrella review of meta‐analyses of observational studiesCancer Medicine, 2020
- Diagnosis, prevalence, and clinical impact of sarcopenia in COPD: a systematic review and meta‐analysisJournal of Cachexia, Sarcopenia and Muscle, 2020
- Recent Progress in Sarcopenia Research: a Focus on Operationalizing a Definition of SarcopeniaCurrent Osteoporosis Reports, 2018
- Sarcopenic obesity or obese sarcopenia: A cross talk between age-associated adipose tissue and skeletal muscle inflammation as a main mechanism of the pathogenesisAgeing Research Reviews, 2017
- Prevalence of and Trends in Diabetes Among Adults in the United States, 1988-2012JAMA, 2015